Study of the Impact of the Regular Consumption of Polyphenol-rich Grape Juice on the Biological Parameters of Oxidative Stress and on Endothelial Function in Healthy Subjects
NCT ID: NCT02028936
Last Updated: 2019-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
117 participants
INTERVENTIONAL
2013-10-24
2014-06-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Polyphenols, notably those present in red grapes, have a certain antioxidant effect. Dietary supplementation with polyphenols in high-risk patients could diminish the harmful consequences of oxidative stress.
The aim of this study is to show that the daily consumption of grape juice rich in polyphenols " R@isol ", has a positive impact on the oxidation/antioxidation balance in healthy volunteers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioavailability of the Polyphenols Contained in a Red Grape Extract-based Drink and Their Metabolic Effects
NCT02865278
Randomized, Double-blind, Controlled Study to Evaluate the Effect of Concord Grape Extract on Vascular Function in Healthy Men and Women
NCT03553225
Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function
NCT00554242
Effects of Dietary Antioxidants to Prevent Cardiovascular Disease
NCT02409537
Grape Pomace Polyphenols and Cardiometabolic Risk
NCT03076463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Grape juice rich in polyphenols
Grape juice R@isol
grape juice not enriched with polyphenols
Commercially-available grape juice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Grape juice R@isol
Commercially-available grape juice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women
* With national health insurance cover
* With a Body Mass Index between 18.5 and 27.9
* Who have given their written informed consent to take part in the study.
Exclusion Criteria
* Adults under ward of court.
* Those in custody following a decision of the court or the administration.
* Subjects with a risk of a major change in their diet during the trial.
* Those who drink more than 5 cups of tea or coffee a day.
* Those who consumed more than 25 grammes of alcohol a day, every day of the year preceding the inclusion visit.
* Those who present a history of or current use of psycho-active substances (drugs such as cocain, morphine, heroin...).
* Subjects currently in a period of exclusion relative to another research protocol or for whom the annual cummulation of payments for participation in biomedical research has reached the annual ceiling.
* Presence of any treated chronic disease, and any acute disease within the 4 weeks preceding the inclusion and randomisation visit.
* Persons with diabetes treated with insulin or oral antidiabetics.
* Subjects on lipid-lowering therapy and/or on antioxidants (such as vitamin E, vitamin C, selenium, ß-carotene, Zinc) in the month preceding inclusion.
* Subjects taking multivitamin supplements in the month preceding inclusion.
* Pregnant or breast-feeding women
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Name CHU Dijon
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BARDOU FUI 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.